Fr   De

Extended Duration of Efficacy of Vardenafil When Taken 8 Hours Before Intercourse: A Randomized, Double-Blind, Placebo-Controlled Study

Other > 20 mg vardenafil


Vardenafil dose may need to be reduced

2 Methods

griseofulvingriseofulvin will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. griseofulvin will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. haloperidolhaloperidol and vardenafil both increase QTc interval. haloperidol and vardenafil both increase QTc interval. hydrocortisonehydrocortisone will decrease the level or effect of vardenafil by affecting cenforce 100 soft hepatic/intestinal enzyme CYP3A4 metabolism.

Are you currently using Vardenafil (Levitra, Staxyn)?

hydrocortisone will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. hydroxyzinehydroxyzine and vardenafil both increase QTc interval. hydroxyzine and vardenafil both increase QTc interval. ibrexafungerpibrexafungerp will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors imatinibimatinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Key Takeaways

Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors imatinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors Drugs that are known to prolong the QTc interval may have an increased the risk of ventricular arrhythmias. Drugs that are known to prolong the QTc interval may have an increased the risk of ventricular arrhythmias. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors isavuconazonium sulfate will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors isoniazidisoniazid will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. if coadministered with moderate or strong CYP3A4 inhibitors

Study Percentage of Effectiveness Notes
Clinical Trial A 75% Improved erectile function
Clinical Trial B 80% Patient satisfaction rate
Post-Marketing Reports 78% Overall effectiveness observed

larotrectinib will increase the level or effect

Product Dosage Quantity + Bonus Price
Viagra Generic25mg20 Pills37.74€ 35.94€
Viagra Original100mg12 Pills72.54€ 69.09€
Apcalis SX Oral Jelly20mg10 Sachets58.75€ 55.95€
Levitra Generic40mg270 + 10 Pills561.89€ 535.13€
Levitra Generic10mg20 Pills46.54€ 44.32€
Cialis Super Active20mg10 Pills55.64€ 52.99€
Cialis Original20mg92 + 4 Pills377.99€ 359.99€
Viagra Super Active100mg30 + 6 Pills64.09€ 61.04€
Cialis Professional40mg90 + 2 Pills348.59€ 331.99€
Cialis Generic40mg90 + 6 Pills171.35€ 163.19€
Viagra Generic50mg270 + 8 Pills198.48€ 189.03€
Viagra Generic200mg120 + 8 Pills204.80€ 195.05€
Cialis Black80mg360 + 20 Pills639.78€ 609.31€
Viagra Soft Tabs100mg20 Pills62.99€ 59.99€
Viagra Generic150mg120 + 8 Pills177.58€ 169.12€

of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors

Symptoms And Signs Of Menopause

Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fluconazole will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fludrocortisonefludrocortisone will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. fludrocortisone will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. fluvoxaminefluvoxamine will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fluvoxamine will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

What should I tell my healthcare provider before taking vardenafil?

Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fosamprenavirfosamprenavir will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fosamprenavir will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fosaprepitantfosaprepitant will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fosaprepitant will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fosfomycinfosfomycin and vardenafil both increase QTc interval.

How Long Do They Take to Work?

The risk of QT prolongation may increase in patients with electrolyte abnormalities (such as hypokalemia and hypocalcemia), patients with conditions that have potential to cause electrolyte imbalance (such as renal impairment), or patients taking other drugs affecting electrolyte balance or QT prolongation; avoid this drug in patients with known QT prolongation or ventricular arrhythmias, including a history of torsade de pointes; monitor electrolytes during treatment fosfomycin and vardenafil both increase QTc interval. The risk of QT prolongation may increase in patients with electrolyte abnormalities (such as hypokalemia and hypocalcemia), patients with conditions that have potential to cause electrolyte imbalance (such as renal impairment), or patients taking other drugs affecting electrolyte balance or QT prolongation; avoid this drug in patients with known QT prolongation or ventricular arrhythmias, including a history of torsade de pointes; monitor electrolytes during treatment fosphenytoinfosphenytoin will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. fosphenytoin will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. fostamatinibfostamatinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fostamatinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. lenacapavirlenacapavir will increase the level or effect

What factors change the timing of menopause?

Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fostemsavirvardenafil and fostemsavir both increase QTc interval. QTc prolongation reported with higher than recommended doses of fostemsavir. vardenafil and fostemsavir both increase QTc interval. gemifloxacingemifloxacin and vardenafil both increase QTc interval. gemifloxacin and vardenafil both increase QTc interval.

Sustained efficacy and tolerability of vardenafil (Levitra®), a highly potent, selective phosphodiesterase-5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial

gepirone and vardenafil both increase QTc interval. gepotidacingepotidacin cenforce 200 mg increases levels of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. If possible, avoid with sensitive substrates that are are extensively metabolized by CYP3A4 and have a narrow therapeutic index. If unable to avoid, monitor or modify substrate dose according to its prescribing information. gepotidacin increases levels of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

How does vardenafil work (mechanism of action)?

gilteritinib and vardenafil both increase QTc interval. granisetrongranisetron and vardenafil both increase QTc interval. granisetron and vardenafil both increase QTc interval. grapefruitgrapefruit will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. grapefruit will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

  • Vardenafil can cause side effects like headaches and flushing.
  • It should not be taken with nitrate medications due to risk of blood pressure drop.
  • Alcohol can increase side effects when combined with vardenafil.
  • Consult a doctor before starting vardenafil to check for contraindications.

Lencapavir may increase CYP3A4 substrates initiated within 9 months after last SC dose

  • Vardenafil is sometimes used off-label for pulmonary arterial hypertension.
  • Use caution when combining with other vasodilators or certain antidepressants.
  • The drug is often prescribed after diagnosis of erectile dysfunction by a clinician.
  • It’s essential to follow the prescribed course and not self-medicate.

of lenacapavir, which may increase potential risk of adverse reactions of CYP3A4 substrates.

Storage Condition Recommended Temperature Shelf Life
Temperature Range 15-30°C Up to 2 years
Light Protection Keep in original container Avoid direct sunlight
Humidity Dry place Prevent degradation

lenacapavir will increase the level or effect

Condition Explanation Risk Level
Use with Nitrates Can cause dangerous hypotension High
Severe Liver Impairment May affect drug metabolism Moderate
Heart Conditions Especially unstable angina or recent heart attack High
Retinitis Pigmentosa Potential risk due to PDE6 expression in retina Caution

of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Vardenafil Generic Name & Formulations

Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors isoniazid will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors istradefyllineistradefylline will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Istradefylline 40 mg/day increased peak levels and AUC of CYP3A4 substrates in clinical trials. This creams for erectile dysfunction effect was not observed with istradefylline 20 mg/day. Consider dose reduction of sensitive CYP3A4 substrates.

What are common drug interactions for vardenafil and sildenafil?

istradefylline will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. itraconazoleitraconazole will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. itraconazole will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ivacaftorivacaftor will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors ivacaftor will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

What are the most common side effects of vardenafil?

Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors ketoconazoleketoconazole will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ketoconazole will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. lapatiniblapatinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors lapatinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors larotrectiniblarotrectinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

 
 
© 2026 cranio-fribourg.ch | Legal Notice | Privacy Policy | by WebMultiMedia

Accept Privacy Policy

This website uses cookies and JavaScript. For more information, please see our Privacy Policy.